对罕见疾病的药物重新定位:罕见疾病社区的进展和机遇
Anneliene Hechtelt Jonker1,2, Daniel O'Connor2,3, Maria Cavaller-Bellaubi2,4
1Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, Netherlands.
Frontiers in medicine
|February 1, 2024
概括
药物再利用为罕见疾病提供了一个重要的策略. 关键的教训包括数据共享和早期监管参与,以及人工智能和患者参与等新兴趋势,以推进罕见疾病治疗.
科学领域:
- 药理学和药物开发领域
- 罕见疾病研究研究 罕见疾病研究
- 公共卫生政策 公共卫生政策
背景情况:
- 药物重新定位是解决罕见疾病中大量未满足的治疗需求的关键策略.
- 从小人群条件下先前的药物重定向举措中吸取的经验教训强调了合作和早期参与的重要性.
- 罕见病景观为治疗开发带来了独特的挑战和机会.
研究的目的:
- 分析从过去的药物重定向努力中学到的关键经验教训,用于罕见疾病.
- 探索新兴趋势及其对罕见病生态系统的潜在影响.
- 确定推进罕见病药物重定向的战略.
主要方法:
- 审查病例研究和先前在罕见疾病中药物重定位方面的工作.
- 分析当前和即将到来的趋势,包括创新平台,现实数据,人工智能,监管举措和患者参与.
- 综合发现,为未来的药物重用策略提供信息.
主要成果:
- 关键的教训包括分享临床观察的价值,寻求早期的监管科学建议,并促进公私合作.
- 新兴趋势,如创新平台,现实世界的数据利用,人工智能 (AI),具体的监管举措和全面的患者参与,将对罕见病药物开发产生重大影响.
- 这些趋势为加速罕见病生态系统中的药物重用过程提供了新的途径.
结论:
- 药物重新定位对罕见疾病具有巨大的前景,利用现有知识和新的方法.
- 将经验教训与新兴趋势相结合,可以优化罕见病药物重定向的效率和成功.
- 药物重用方面的进展最终将使患者,公共卫生和更广泛的药物开发领域受益.
相关概念视频
Prescription, Nonprescription and Orphan Drugs
733
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
733
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Structure-Activity Relationships and Drug Design
721
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
721
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Prodrugs
2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.6K
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K


